Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QDPR | P09417 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.53 |
| ▸ | HTR6 | P50406 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16862164 | 1.00 | QDPR (0.67) | QDPRKDM4ELMNAPOLBHTR1A | |
| Hydrochloric Acid SCHEMBL1148906 | 0.98 | QDPR (0.65) | QDPRKDM4ELMNAPOLBHTR1A | |
| Bromide SCHEMBL11557389 | 0.98 | QDPR (0.65) | QDPRKDM4ELMNAPOLBHTR1A | |
| Ammonia Solution, Strong SCHEMBL15875021 | 0.98 | QDPR (0.65) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL13898494 | 0.96 | QDPR (0.68) | QDPRKDM4ELMNAPOLBHTR1A | |
| Hydrochloric Acid SCHEMBL19717522 | 0.96 | QDPR (0.62) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL16565762 | 0.88 | QDPR (0.53) | QDPRNPC1RAB9AKMT2A | |
| Hydrochloric Acid SCHEMBL6517404 | 0.84 | QDPR (0.50) | QDPRKDM4ELMNAPOLBHTR1A | |
| SCHEMBL8264178 | 0.83 | QDPR (0.59) | QDPRSLC6A4 | |
| SCHEMBL7369176 | 0.83 | QDPR (0.72) | QDPRSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9108 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121610414-B | Saliva combined lactobacillus and application thereof in preparation of medicines for relieving parkinsonism | 南昌大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4713433-A2 | LIVER ORGANOIDS WITH INTRAHEPATIC SYMPATHETIC NERVES, AND METHODS OF USE THEREOF | Children's Hospital Medical Center (US) | 2026-03-25 | — | — | EP | claimed |
| US-20260076969-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-03-19 | — | — | US | claimed |
| CN-121574923-A | Construction method of parkinsonism-brain organoids and application of parkinsonism-brain organoids in screening parkinsonism treatment medicines | 黑龙江中医药大学 | 2026-02-27 | — | — | CN | claimed |
| EP-4658795-A1 | GENE THERAPY VECTORS FOR USE IN PARKINSON'S DISEASE | Janssen Pharmaceutica NV (BE) | 2025-12-10 | — | — | EP | claimed |
| EP-4652162-A1 | INHIBITORS OF MPTP | NRG Therapeutics LTD (GB) | 2025-11-26 | — | — | EP | claimed |
| EP-4651954-A1 | INHIBITORS OF MPTP | NRG Therapeutics LTD (GB) | 2025-11-26 | — | — | EP | claimed |
| US-20250228771-A1 | ALKALINE INTRAORAL PRODUCTS | EMPLICURE AB (publ) (SE) | 2025-07-17 | — | — | US | claimed |
| CN-120157660-A | Icaritin derivative and application thereof | 青岛大学 | 2025-06-17 | — | — | CN | claimed |
| CN-120145652-A | Welding beam engineering reliability design optimization method based on Kriging and sparrow search | 电子科技大学 | 2025-06-13 | — | — | CN | claimed |
| EP-1212353-A4 | SMALL CYCLIC MIMICS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) | UNIV MELBOURNE (AU) | 2004-10-20 | — | — | EP | claimed |
| US-20030143208-A1 | Oxidative stress-resistant cell lines and methods of use thereof | CHILDREN'S HOSPITAL OF PHILADELPHIA, THE | 2003-07-31 | — | — | US | claimed |
| US-20030108893-A1 | Method for establishing neurogically relevant properties of a material | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2003-06-12 | — | — | US | claimed |
| US-20030023994-A1 | Assay for toxin induced neuronal degeneration and viability in C. elegans | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-01-30 | — | — | US | claimed |
| WO-2003001197-A1 | ASSAY FOR TOXIN INDUCED NEURONAL DEGENERATION AND VIABILITY IN C. ELEGANS | VANDERBILT UNIVERSITY (US) | 2003-01-03 | — | — | WO | claimed |
| EP-1212353-A1 | SMALL CYCLIC MIMICS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) | THE UNIVERSITY OF MELBOURNE (AU) | 2002-06-12 | — | — | EP | claimed |
| EP-0656791-B1 | THERAPEUTIC COMPOSITIONS COMPRISING PQQ AND A REDUCING AGENT | CHILDRENS MEDICAL CENTER (US) | 2002-06-05 | — | — | EP | claimed |
| US-6232326-B1 | SUFFICIENT TO REDUCE DOPAMINE LEVELS IN SUBCORTICAL AREAS OF THE BRAIN WITHOUT CAUSING SYMPTOMS OF PARKINSON'S DISEASE; PERMANENT OR LONG-TERM AMELIORATION OF SYMPTOMS | ALPHA RESEARCH GROUP, LLC | 2001-05-15 | — | — | US | claimed |
| WO-2000075176-A1 | SMALL CYCLIC MIMICS OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) | THE UNIVERSITY OF MELBOURNE (AU) | 2000-12-14 | — | — | WO | claimed |
| WO-2000003713-A1 | TREATMENT FOR SCHIZOPHRENIA AND OTHER DOPAMINE SYSTEM DYSFUNCTIONS | NELSON JODI A (US) | 2000-01-27 | — | — | WO | claimed |